High-sensitivity C-reactive Protein Can Predict Major Adverse Cardiovascular Events in Korean Patients with Type 2 Diabetes

被引:11
作者
Lee, Sangheun [1 ]
Kim, In Tae [1 ]
Park, Hyung Bok [1 ]
Hyun, Yu Kyung [1 ]
Kim, Yoon Ji [1 ]
Song, Sun Ok [1 ]
Kim, Hyeongjin [2 ]
机构
[1] Kwandong Univ, Dept Internal Med, Coll Med, Goyang 412270, South Korea
[2] Kwandong Univ, Dept Endocrinol, Coll Med, Goyang 412270, South Korea
关键词
C-Reactive protein; Diabetes Mellitus; Type; 2; Cardiovascular Diseases; Hazard Ratio; DENSITY-LIPOPROTEIN CHOLESTEROL; HEALTH-CARE PROFESSIONALS; HEART-DISEASE MORTALITY; INFLAMMATION; RISK; STATEMENT; MARKERS; PLASMA; ADULTS;
D O I
10.3346/jkms.2011.26.10.1322
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Inflammation is thought to play a role in the pathogenesis of major adverse cardiovascular events (MACE). It has been suggested that the measurement of markers of inflammation may aid in predicting the risk of such events. Here, the relationship between high-sensitivity C-reactive protein (hs-CRP) levels and MACE in Korean patients with type 2 diabetes is assessed. A retrospective cohort study was conducted as a follow-up among 1,558 patients with type 2 diabetes and without cardiovascular diseases over a mean period of 55.5 months. A Cox proportional-hazards model was used to determine whether increased hs-CRP levels are useful as a predictor for future MACE. The hazard ratio of MACE was 1.77 (95% CI; 1.16-2.71) in subjects who had the highest hs-CRP levels (> 0.21 mg/dL) compared to subjects who had the lowest hs-CRP levels (< 0.08 mg/dL), after adjusting for age, regular physical activity, current smoking, and duration of diabetes. The present results indicate that high hs-CRP levels can act as a predictor for the MACE occurrence in Korean patients with type 2 diabetes.
引用
收藏
页码:1322 / 1327
页数:6
相关论文
共 29 条
[1]   ATHEROGENESIS IN DIABETES [J].
BIERMAN, EL .
ARTERIOSCLEROSIS AND THROMBOSIS, 1992, 12 (06) :647-656
[2]   C-Reactive Protein and 5-Year Survival in Type 2 Diabetes The Casale Monferrato Study [J].
Bruno, Graziella ;
Fornengo, Paolo ;
Novelli, Giulia ;
Panero, Francesco ;
Perotto, Massimo ;
Segre, Olivia ;
Zucco, Chiara ;
Deambrogio, PierCarlo ;
Bargero, Giuseppe ;
Perin, Paolo Cavallo .
DIABETES, 2009, 58 (04) :926-933
[3]  
FRIEDEWALD WT, 1972, CLIN CHEM, V18, P499
[4]  
Grundy Scott M, 2004, J Am Coll Cardiol, V44, P720, DOI 10.1016/j.jacc.2004.07.001
[5]   Diabetes and cardiovascular disease - A statement for healthcare professionals from the American Heart Association [J].
Grundy, SM ;
Benjamin, IJ ;
Burke, GL ;
Chait, A ;
Eckel, RH ;
Howard, BV ;
Mitch, W ;
Smith, SC ;
Sowers, JR .
CIRCULATION, 1999, 100 (10) :1134-1146
[6]  
Hartge Martin M, 2007, Diab Vasc Dis Res, V4, P84
[7]   C-reactive protein is an independent predictor of the rate of increase in early carotid atherosclerosis [J].
Hashimoto, H ;
Kitagawa, K ;
Hougaku, H ;
Shimizu, Y ;
Sakaguchi, M ;
Nagai, Y ;
Iyama, S ;
Yamanishi, H ;
Matsumoto, M ;
Hori, M .
CIRCULATION, 2001, 104 (01) :63-67
[8]  
JO HJ, 2007, J KOREAN NEUROL ASS, V25, P70
[9]   Relationship of serum high sensitivity C-reactive protein to metabolic syndrome and microvascular complications in type 2 diabetes [J].
Kang, ES ;
Kim, HJ ;
Ahn, CW ;
Park, CW ;
Cha, BS ;
Lim, SK ;
Kim, KR ;
Lee, HC .
DIABETES RESEARCH AND CLINICAL PRACTICE, 2005, 69 (02) :151-159
[10]   LIPIDS AND LIPOPROTEINS PREDICTING CORONARY HEART-DISEASE MORTALITY AND MORBIDITY IN PATIENTS WITH NON-INSULIN-DEPENDENT DIABETES [J].
LAAKSO, M ;
LEHTO, S ;
PENTTILA, I ;
PYORALA, K .
CIRCULATION, 1993, 88 (04) :1421-1430